Reuters logo
BRIEF-Asit Biotech says active ingredients used in ASIT+ granted European patent
October 17, 2017 / 4:43 PM / a month ago

BRIEF-Asit Biotech says active ingredients used in ASIT+ granted European patent

Oct 17 (Reuters) - ASIT BIOTECH SA:

* ASIT BIOTECH ANNOUNCES THE GRANT OF A EUROPEAN PATENT ON THE ACTIVE INGREDIENTS USED IN THE ASIT+™ ALLERGY IMMUNOTHERAPY PRODUCT CANDIDATES

* ‍GRANT WILL BE EFFECTIVE FROM NOVEMBER 1, 2017 UNTIL JUNE 28, 2027 WITH A POSSIBLE EXTENSION OF 5 YEARS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below